Skip to main content

CTTC

Robot prototype shows promise for microsurgery on eyes and aneurysms

Nov. 14, 2019—A new continuum robot designed by Vanderbilt engineers achieves multiscale motion and may open up a huge world of previously impossible complex microsurgeries.

Read more


Biophotonics device for parathyroid I.D. is a R&D 100 Awards finalist

Oct. 28, 2019—An optical imaging technology developed by Orrin H. Ingram Professor of Biomedical Engineering Anita Mahadevan-Jansen and her group, in partnership with a medical device company, has been selected as a finalist for the 2019 R&D 100 Awards.

Read more


Soldiers partner with Vanderbilt engineers to create new model for innovation

Oct. 21, 2019—Soldiers from the 3rd Brigade Combat Team of the 101st Airborne Division at Fort Campbell, Kentucky, and researchers at Vanderbilt's School of Engineering are building a partnership to identify and solve tactical problems with soldier-inspired solutions.

Read more


Hand-held robot points to less invasive prostate surgery

Jul. 18, 2019—Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.

Read more


Hand-held robot points to less invasive prostate surgery

Jul. 18, 2019—Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options. A key part of the design – telescoping, curved, concentric tubes – received U.S. patent protection in March 2019, the same month the principal investigators secured a $2.1 million R01...

Read more


Ancora Innovation proposal submissions open March 14

Feb. 26, 2019—This is the second request for proposals to Ancora since Vanderbilt and Deerfield launched their collaboration in 2018 with a commitment from Deerfield of up to $65 million in initial funding over five years to support promising drug discovery research.

Read more


Therapeutic Antibody Discovery and Development event is Jan. 23

Jan. 2, 2019—Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field.

Read more


Therapeutic Antibody Discovery and Development event is Jan. 23

Dec. 19, 2018—The event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield.

Read more


FDA approves device based on Vanderbilt invention to ID parathyroid during head and neck surgeries

Dec. 17, 2018—Ten years after Professor of Biomedical Engineering Anita Mahadevan-Jansen discovered that parathyroid tissues glow under near-infrared light, the FDA has approved a device based on the technology for surgical use.

Read more


Ancora announces major funding awards to support Vanderbilt drug discovery research

Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.

Read more


Business Valuation Seminar 2018 at Wond’ry Nov. 7

Oct. 19, 2018—Nashville-based valuation expert Glenn Perdue will lead a seminar on the valuation process of early-stage businesses on Wednesday, Nov. 7, at the Wond'ry.

Read more


CTTC to host session on funding opportunities for physicians, scientists developing new therapies

Oct. 7, 2018—Vanderbilt's Center for Technology Transfer and Commercialization will host a session on Oct. 16 with the Harrington Discovery Institute to explore funding opportunities for physicians and scientists who are developing new therapies.

Read more


VIEW MORE EVENTS >